⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

January 1, 2012Frontiers in PhysiologyOpen Access

Reactive oxygen species-targeted therapeutic interventions for atrial fibrillation

View Full Paper

Ask AI

Bookmark

Share

Design

Review

Authors

ASAli A. SovariElectrophysiology SDSamuel C. DudleyElectrophysiology

Discussion

Loading...

Member takes

Implication

May guide source-specific ROS inhibition trials in AF; leaves open clinical efficacy confirmation.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sovari et al. (2012) studied this question.

synapsesocial.com/papers/6a10d0c48102eb4b66ee773c https://doi.org/10.3389/fphys.2012.00311

Topics

Atrial fibrillation Persistent AF management Anticoagulation in AF AF ablation outcomes

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Valsartan for Prevention of Recurrent Atrial Fibrillation2009 · 444 citations
2Hypoxic modulation of cardiac -type Ca current: Interaction of reactive oxygen species and β-adrenergic signaling2005 · 5 citations
3Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial Infarction1989 · 3,314 citations
4A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction1995 · 1,781 citations
5The sensitivity of pancreatic β-cells to mitochondrial injuries triggered by lipotoxicity and oxidative stress2008 · 117 citations